{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:42:48Z","timestamp":1793421768073,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10549-018-4824-9","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T09:58:11Z","timestamp":1527501491000},"page":"435-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect"],"prefix":"10.1007","volume":"171","author":[{"given":"Alexander","family":"Liede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara Fidler","family":"Crouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Niepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"4824_CR1","unstructured":"Jolie A (2013) My medical choice. New York Times, May 14, 2013. \n                    http:\/\/www.nytimes.com\/2013\/05\/14\/opinion\/my-medical-choice.html\n                    \n                  . Accessed 20 May 2013"},{"issue":"7","key":"4824_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431","journal-title":"J Med Genet"},{"issue":"3","key":"4824_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73(3):643\u2013651","journal-title":"Cancer"},{"key":"4824_CR4","doi-asserted-by":"publisher","first-page":"f3829","DOI":"10.1136\/bmj.f3829","volume":"346","author":"DG Evans","year":"2013","unstructured":"Evans DG, Graham J, O\u2019Connell S, Arnold S, Fitzsimmons D (2013) Familial breast cancer: summary of updated NICE guidance. BMJ 346:f3829","journal-title":"BMJ"},{"issue":"24","key":"4824_CR5","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879\u20131886","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4824_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/M13-2747","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160(4):271\u2013281","journal-title":"Ann Intern Med"},{"issue":"8","key":"4824_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1701-2163(15)30856-2","volume":"35","author":"J Nisker","year":"2013","unstructured":"Nisker J (2013) A public health education initiative for women with a family history of breast\/ovarian cancer: why did it take Angelina Jolie? J Obstet Gynaecol Can 35(8):689\u2013691","journal-title":"J Obstet Gynaecol Can"},{"key":"4824_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","volume":"16","author":"DG Evans","year":"2014","unstructured":"Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, Donaldson A, Brady AF, Cuthbert A, Harrison R et al (2014) The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res 16:442\u2013446","journal-title":"Breast Cancer Res"},{"key":"4824_CR9","doi-asserted-by":"publisher","first-page":"i6357","DOI":"10.1136\/bmj.i6357","volume":"355","author":"S Desai","year":"2016","unstructured":"Desai S, Jena AB (2016) Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie\u2019s New York Times editorial. BMJ 355:i6357","journal-title":"BMJ"},{"key":"4824_CR10","unstructured":"US Census Bureau. \n                    https:\/\/factfinder.census.gov\/faces\/tableservices\/jsf\/pages\/productview.xhtml?pid=ACS_16_1YR_B01001&prodType=table\n                    \n                  . Accessed 5 Dec 2017"},{"issue":"4","key":"4824_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S0266462303000576","volume":"19","author":"CR Ramsay","year":"2003","unstructured":"Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE (2003) Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 19(4):613\u2013623","journal-title":"Int J Technol Assess Health Care"},{"issue":"7624","key":"4824_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806\u2013808","journal-title":"BMJ"},{"issue":"6","key":"4824_CR13","first-page":"346","volume":"17","author":"LJ Logue","year":"2003","unstructured":"Logue LJ (2003) Genetic testing coverage and reimbursement: a provider\u2019s dilemma. Clin Leadersh Manag Rev 17(6):346\u2013350","journal-title":"Clin Leadersh Manag Rev"},{"key":"4824_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/CLEP.S105613","volume":"9","author":"KE Mues","year":"2017","unstructured":"Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, Collins AJ, Gilbertson DT (2017) Use of the medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol 9:267\u2013277","journal-title":"Clin Epidemiol"},{"key":"4824_CR15","unstructured":"National Human Genome Research Institute (NHGRI): The Genetic Information Nondiscrimination Act (GINA) of 2008. \n                    https:\/\/www.genome.gov\/27568492\/the-genetic-information-nondiscrimination-act-of-2008\/\n                    \n                  . Accessed 21 Dec 2017"},{"key":"4824_CR16","unstructured":"U.S. Department of Health and Human Services: Affordable Care Act. \n                    https:\/\/www.hhs.gov\/healthcare\/about-the-aca\/index.html\n                    \n                  . Accessed 21 Dec 2017"},{"key":"4824_CR17","doi-asserted-by":"crossref","unstructured":"Gregorowitsch ML, van den Bongard H, Young-Afat DA, Pignol JP, van Gils CH, May AM, Verkooijen HM (2017) Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients. Breast Cancer Res Treat","DOI":"10.1007\/s10549-017-4495-y"},{"issue":"41","key":"4824_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/jncimonographs\/lgq029","volume":"2010","author":"PA Ganz","year":"2010","unstructured":"Ganz PA (2010) Quality-of-life issues in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010(41):218\u2013222","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"4824_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.breast.2010.03.024","volume":"19","author":"F Kennedy","year":"2010","unstructured":"Kennedy F, Harcourt D, Rumsey N, White P (2010) The psychosocial impact of ductal carcinoma in situ (DCIS): a longitudinal prospective study. Breast 19(5):382\u2013387","journal-title":"Breast"},{"issue":"5","key":"4824_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/0284186X.2017.1295167","volume":"56","author":"BG Mertz","year":"2017","unstructured":"Mertz BG, Duriaud HM, Kroman N, Andersen KG (2017) Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study. Acta Oncol 56(5):724\u2013729","journal-title":"Acta Oncol"},{"issue":"3","key":"4824_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajmg.a.10168","volume":"119A","author":"L Lodder","year":"2003","unstructured":"Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF (2003) Attitudes and distress levels in women at risk to carry a BRCA1\/BRCA2 gene mutation who decline genetic testing. Am J Med Genet A 119A(3):266\u2013272","journal-title":"Am J Med Genet A"},{"issue":"5","key":"4824_CR22","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","volume":"16","author":"C Lerman","year":"1998","unstructured":"Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT (1998) What you don\u2019t know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 16(5):1650\u20131654","journal-title":"J Clin Oncol"},{"issue":"4","key":"4824_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajmg.c.30104","volume":"142C","author":"SC O\u2019Neill","year":"2006","unstructured":"O\u2019Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, Valdimarsdottir H, Schwartz MD (2006) Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1\/2 test results. Am J Med Genet C Semin Med Genet 142C(4):251\u2013259","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"12","key":"4824_CR24","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1158\/1055-9965.EPI-05-0512","volume":"14","author":"M Dorval","year":"2005","unstructured":"Dorval M, Gauthier G, Maunsell E, Dugas MJ, Rouleau I, Chiquette J, Plante M, Laframboise R, Gaudet M, Bridge PJ et al (2005) No evidence of false reassurance among women with an inconclusive BRCA1\/2 genetic test result. Cancer Epidemiol Biomark Prev 14(12):2862\u20132867","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"4824_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/gtmb.2008.0126","volume":"13","author":"S Ertmanski","year":"2009","unstructured":"Ertmanski S, Metcalfe K, Trempala J, Glowacka MD, Lubinski J, Narod SA, Gronwald J (2009) Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genet Test Mol Biomark 13(3):325\u2013330","journal-title":"Genet Test Mol Biomark"},{"issue":"2","key":"4824_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10549-011-1941-0","volume":"133","author":"KA Metcalfe","year":"2012","unstructured":"Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA (2012) Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat 133(2):735\u2013740","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4824_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1897-4287-12-9","volume":"12","author":"GW Hooker","year":"2014","unstructured":"Hooker GW, King L, Vanhusen L, Graves K, Peshkin BN, Isaacs C, Taylor KL, Poggi E, Schwartz MD (2014) Long-term satisfaction and quality of life following risk reducing surgery in BRCA1\/2 mutation carriers. Hered Cancer Clin Pract 12(1):9","journal-title":"Hered Cancer Clin Pract"},{"key":"4824_CR28","doi-asserted-by":"crossref","unstructured":"Liede A, Fairchild A, Friedman S, Amelio J, Hallett DC, Mansfield CA, Metcalfe KA (2016) Abstract P2-09-09: risk-reducing surgery and cancer-related distress among female BRCA1 and BRCA2 mutation carriers, vol\u00a076","DOI":"10.1158\/1538-7445.SABCS15-P2-09-09"},{"key":"4824_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13058-015-0650-8","volume":"17","author":"DG Evans","year":"2015","unstructured":"Evans DG, Wisely J, Clancy T, Lalloo F, Wilson M, Johnson R, Duncan J, Barr L, Gandhi A, Howell A (2015) Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women. Breast Cancer Res 17:143","journal-title":"Breast Cancer Res"},{"key":"4824_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/CLEP.S92209","volume":"7","author":"A Liede","year":"2015","unstructured":"Liede A, Hernandez RK, Roth M, Calkins G, Larrabee K, Nicacio L (2015) Validation of international classification of diseases coding for bone metastases in electronic health records using technology-enabled abstraction. Clin Epidemiol 7:441\u2013448","journal-title":"Clin Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T23:16:34Z","timestamp":1558998994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4824"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4824-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"assertion":[{"value":"19 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This research was not supported by any specific funding. Statistical analysis and writing support provided by Amgen Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}